Hengrui Medicine (01276): HRS-2189 Tablets Approved to Initiate Clinical Trials

date
28/10/2026
Zhitong Finance APP News, Hengrui Pharmaceuticals (01276) announced that recently, the company's subsidiary Shandong Shengdi Pharmaceutical Co., Ltd. received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration for HRS-2189 tablets, and will soon initiate clinical trials.
Latest
See all latestmore